Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903)

BACKGROUND: Neoadjuvant therapy plus oesophagectomy has been accepted as the standard treatment for patients with potentially curable locally advanced oesophageal cancer. No completed randomized controlled trial (RCT) has directly compared neoadjuvant chemotherapy and neoadjuvant chemoradiation in p...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Sun, Hai-Bo, Xing, Wen-Qun, Liu, Xian-Ben, Zheng, Yan, Yang, Shu-Jun, Wang, Zong-Fei, Liu, Shi-Lei, Ba, Yu-Feng, Zhang, Rui-Xiang, Liu, Bao-Xing, Fan, Cheng-Cheng, Chen, Pei-Nan, Liang, Guang-Hui, Yu, Yong-Kui, Liu, Qi, Wang, Hao-Ran, Li, Hao-Miao, Li, Zhen-Xuan
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7158003/
https://ncbi.nlm.nih.gov/pubmed/32293362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-06824-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky